MEDP: Medpace Holdings, Inc. Company Short-Term Debt

Symbol and logo of brand Medpace Holdings (MEDP)

Medpace Holdings, Inc. (MEDP) provides multi-year support for biotechnology projects, creating sustainable cash flows through strict process regulation. On GURU.Markets, credit obligations of up to one year are available in real-time, with the latest mark standing at 0.02, which is critical given the strict temperature control requirements for drug delivery. High demand for research guarantees the company excellent margins and a stable liquidity surplus.

MEDP (Medpace Holdings) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

Medpace Corp (MEDP) - metric breakdowns and financial figures

- current quotes and average value forecast:
Price Chart Medpace|MEDP - Fair Value Consensus
- market capitalization information:
Market Value Medpace Holdings|MEDP - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Medpace|MEDP - Book Capitalization|Market Cap to Net Assets Ratio medpace.com|MEDP - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Equity Ratio Medpace Holdings, Inc.|MEDP - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Medpace Holdings, Inc.|MEDP - Company Cumulative Debt|Debt to Book Capitalization Ratio Medpace Holdings|MEDP - Long-Term Debt Volume|Company Current Liabilities Medpace|Quick Liquidity medpace.com
- net income and valuation multiples indicators:
MEDP - Net Financial Result
Basic company analysis:MEDP - Medpace
Flagship merchandise of Medpace Corp

The Medpace Holdings, Inc. (MEDP) model is based on prepayments for clinical trials, minimizing the need for debt capital. This metric aggregates all obligations with a maturity of up to one year, including short-term loans and current liabilities. It reveals the gap between formal liquidity and the actual debt burden. An increase in this indicator signals a risk of funding shortages by the payment dates. By analyzing the company's short-term liabilities, an investor assesses the stability of the cash flow.

Competitors of Medpace Holdings, Inc.

IQV - Company Short-Term Debt|Company Short-Term Loans and Borrowings LH (Labcorp Holdings)|ICON (ICLR) - Company Short-Term Debt|Company Current Liabilities Charles River Corp|EVO (Evotec SE) - Company Short-Term Debts|Company Short-Term Debts fortrea.com|Company Current Liabilities LFCR (Lifecore Biomedical)|OABI (OmniAb Inc.) - Company Short-Term Loans and Borrowings|Inotiv Corp - Company Current Liabilities|Amount of Current Liabilities CDMO (Avid Bioservices Inc)|Catalent, Inc. - Company Short-Term Debts|Short-Term Debt nighthawkbio.com